These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2089199)

  • 21. Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.
    Keane PE; Kan JP; Sontag N; Benedetti MS
    J Pharm Pharmacol; 1979 Nov; 31(11):752-4. PubMed ID: 41906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of pentazocine and naloxone on the monoamine content of discrete regions of the rat brain.
    Holtzman SG
    Biochem Pharmacol; 1974 Nov; 23(21):3029-35. PubMed ID: 4429600
    [No Abstract]   [Full Text] [Related]  

  • 23. Age-related changes in brain neurotransmission.
    Petkov VD; Petkov VV; Stancheva SL
    Gerontology; 1988; 34(1-2):14-21. PubMed ID: 2898418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y; Weinstock M; Youdim MB
    J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains.
    Riachi NJ; Behmand RA; Harik SI
    Brain Res; 1991 Jul; 555(1):19-24. PubMed ID: 1933326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional effects on the cerebral concentration of noradrenaline, serotonin and dopamine in suckling rats after a single dose of lindane.
    Rivera S; Sanfeliu C; Suñol C; Rodríguez-Farré E
    Toxicology; 1991; 69(1):43-54. PubMed ID: 1718055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
    Waldmeier PC; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of transient ischemia on monoamine levels in the cerebral cortex of gerbils.
    Gaudet R; Welch KM; Chabi E; Wang TP
    J Neurochem; 1978 Apr; 30(4):751-7. PubMed ID: 650215
    [No Abstract]   [Full Text] [Related]  

  • 33. The handling of five amines by the extraneuronal deaminating system of the rat heart.
    Grohmann M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):159-63. PubMed ID: 3368019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 35. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age effects on monoamine turnover of the rat substantia nigra.
    Venero JL; Machado A; Cano J
    Brain Res; 1991 Aug; 557(1-2):109-14. PubMed ID: 1747745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age.
    Bhaskaran D; Radha E
    Exp Gerontol; 1984; 19(3):153-70. PubMed ID: 6479252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving rats.
    Curet O; Damoiseau G; Labaune JP; Rovel V; Jarreau FX
    J Neural Transm Suppl; 1994; 41():349-55. PubMed ID: 7931249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.